Peng Ying-Long, Chen Jinwei, Hu Hengxiao, Liu Wenxiong, Liang Weiye, Wang Jian
Department of Neurobiology, School of Medicine, South China University of Technology, Guangzhou, China.
Neurosci Appl. 2024 Mar 30;3:104061. doi: 10.1016/j.nsa.2024.104061. eCollection 2024.
Parkinson's disease (PD) is a neurological disorder that often affects middle-aged and elderly people. It is primarily characterized by the degeneration of dopaminergic (DA) neurons in the ventral midbrain. Clinical therapy mostly relies on the holistic approach of pharmaceutical intervention and surgical procedures. Nevertheless, therapies might just alleviate symptoms temporarily and then result in notable adverse consequences, ultimately failing to produce a therapeutic outcome. Stem cells has the benefits of being capable of self-renewal and exhibiting multi-directional differentiation potential. This enables replacement of dysfunctional neurons and reconstruction of neural circuit, offering promise for the treatment of Parkinson's disease. This research examines and evaluates the fundamental principles, effectiveness, benefits, and drawbacks of various stem cell types in the treatment of Parkinson's disease. This review provides a concise summary of many potential processes by which stem cells might be effective in treating Parkinson's disease. The aim is to support ongoing research and clinical trials focused on using stem cells for the treatment of Parkinson's disease.
帕金森病(PD)是一种常影响中老年人的神经障碍疾病。其主要特征是中脑腹侧多巴胺能(DA)神经元的退化。临床治疗主要依赖药物干预和手术程序的整体方法。然而,这些疗法可能只是暂时缓解症状,随后会导致显著的不良后果,最终无法产生治疗效果。干细胞具有自我更新和表现出多向分化潜能的优点。这使得功能失调的神经元得以替代,神经回路得以重建,为帕金森病的治疗带来了希望。本研究考察并评估了各种干细胞类型在治疗帕金森病中的基本原理、有效性、益处和缺点。本综述简要总结了干细胞可能有效治疗帕金森病的许多潜在过程。目的是支持正在进行的专注于使用干细胞治疗帕金森病的研究和临床试验。